Yungjin Pharm. Co., Ltd.

Quick facts

Marketed products

• Placebo(for Limaprost)
  Placebo is an inert substance with no active pharmacological mechanism.

Phase 2 pipeline

• YRA-1909 high dose
• YRA-1909 low dose
• YRA-1909 mid dose

Phase 1 pipeline

• MB12066

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Yungjin Pharm. Co., Ltd. portfolio CI brief
• Yungjin Pharm. Co., Ltd. pipeline updates RSS